V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220019218 | 220006843 | 1.6 | 68 | Palliative (P) | 2014-04-22 | 2014-07-07 | Hydroxycarbamide | 2 | N | 220026267 | HYDROXYCARBAMIDE |
| 220019219 | 220006844 | null | 18.3 | Curative (C) | 2017-07-30 | 2017-07-30 | null | N | N | 220026282 | NOT MATCHED |
| 220019220 | 220006852 | 1.67 | 69.3 | Neo-adjuvant (N) | 2016-02-07 | 2016-02-07 | Hydroxycarbamide | N | null | 220026288 | HYDROXYCARBAMIDE |
| 220019222 | 220006860 | 1.75 | 83.3 | Palliative (P) | 2018-08-14 | 2018-08-14 | Cytarabine Low Dose | N | null | 220026317 | CYTARABINE |
| 220019223 | 220013778 | 1.74 | null | null | null | 2015-09-26 | CYTARABINE | N | N | 220026326 | CYTARABINE |
| 220019224 | 220017503 | 1.65 | 18 | Disease modification (D) | 2013-04-01 | 2013-07-07 | AML Relapsed High Dose Cytarabine | N | N | 220026335 | NOT MATCHED |
| 220019225 | 220019598 | null | 68.3 | Disease modification (D) | 2016-10-09 | 2016-10-23 | Hydroxycarbamide | 02 | N | 220026341 | HYDROXYCARBAMIDE |
| 220019226 | 220006873 | 1.62 | 50 | Palliative (P) | 2017-05-05 | 2017-05-05 | CYTARABINE | N | N | 220026357 | CYTARABINE |
| 220019227 | 220006874 | 1.8 | 89.9 | Disease modification (D) | 2013-08-26 | 2013-11-05 | Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE | 02 | N | 220026358 | NOT MATCHED |
| 220019229 | 220006878 | 0 | 69.3 | Palliative (P) | 2018-03-10 | 2018-03-14 | Hydroxycarbamide | N | N | 220026364 | HYDROXYCARBAMIDE |
| 220019230 | 220006880 | null | 82.5 | Disease modification (D) | 2017-05-06 | 2017-05-07 | Hydroxycarbamide | 02 | N | 220026371 | HYDROXYCARBAMIDE |
| 220019231 | 220017509 | 1.72 | 60 | Disease modification (D) | 2015-12-12 | 2016-05-21 | Cytarabine Low Dose | 02 | N | 220026384 | CYTARABINE |
| 220019232 | 220006887 | 1.7 | 98.4 | Palliative (P) | 2019-03-18 | 2019-03-19 | null | N | N | 220026391 | NOT MATCHED |
| 220019233 | 220006888 | 1.83 | null | Curative (C) | 2017-08-19 | 2017-08-20 | null | null | N | 220026394 | NOT MATCHED |
| 220019234 | 220006889 | 1.68 | 56.8 | Palliative (P) | 2013-04-16 | 2014-11-13 | Hydroxycarbamide | N | N | 220026397 | HYDROXYCARBAMIDE |
| 220019235 | 220013797 | 1.75 | 9.1 | Palliative (P) | 2016-12-07 | 2016-12-09 | null | 2 | N | 220026415 | NOT MATCHED |
| 220019236 | 220006892 | 1.73 | 15.85 | Adjuvant (A) | 2014-11-28 | 2014-12-01 | AML MyeChild 01 B Cytarabine/Daunoxome | 02 | N | 220026416 | NOT MATCHED |
| 220019237 | 220006896 | null | null | Palliative (P) | 2018-03-16 | 2018-03-16 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220026455 | CYTARABINE |
| 220019238 | 220006898 | null | null | Palliative (P) | 2013-03-12 | 2013-07-23 | null | N | N | 220026461 | NOT MATCHED |
| 220019239 | 220006900 | null | 49.2 | Curative (C) | 2017-03-05 | 2017-03-19 | AML MyeChild 01 FLA-Idarubicin | null | N | 220026463 | NOT MATCHED |
| 220019240 | 220006903 | 0 | 83.3 | Palliative (P) | 2013-10-26 | 2013-12-07 | Cytarabine low (10to20mg/m2) IV/SC | N | null | 220026471 | CYTARABINE |
| 220019241 | 220006904 | 0 | 74 | Curative (C) | 2016-12-06 | 2016-12-07 | AML Interim Guidelines FLA -Ida | N | N | 220026472 | NOT MATCHED |
| 220019242 | 220006911 | 1.63 | 29.6 | null | 2013-04-17 | 2013-05-24 | Cytarabine + Etoposide + Tretinoin | N | N | 220026504 | NOT MATCHED |
| 220019243 | 220006914 | 1.65 | 57.6 | Disease modification (D) | 2013-08-10 | 2013-10-26 | Hydroxycarbamide | 02 | N | 220026512 | HYDROXYCARBAMIDE |
| 220019244 | 220013814 | null | 104 | Curative (C) | null | 2018-07-10 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220026531 | CYTARABINE |
| 220019245 | 220019606 | null | 47.75 | Curative (C) | 2014-02-02 | 2014-02-02 | AML MyeChild 01 FLA | N | N | 220026533 | NOT MATCHED |
| 220019246 | 220019606 | 1.8 | null | Curative (C) | 2018-04-08 | 2018-06-22 | Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE | N | N | 220026533 | NOT MATCHED |
| 220019247 | 220006918 | 0 | null | Curative (C) | 2016-09-12 | 2016-11-20 | Cytarabine Low Dose | N | null | 220026565 | CYTARABINE |
| 220019248 | 220006921 | 1.77 | null | Palliative (P) | 2017-06-02 | 2017-06-02 | Hydroxycarbamide | N | N | 220026567 | HYDROXYCARBAMIDE |
| 220019249 | 220006924 | null | 96.7 | Curative (C) | 2014-11-15 | 2014-11-15 | Hydroxycarbamide | N | N | 220026577 | HYDROXYCARBAMIDE |
| 220019250 | 220013820 | 0 | 103 | Palliative (P) | 2017-08-16 | 2017-08-16 | Hydroxycarbamide | N | N | 220026587 | HYDROXYCARBAMIDE |
| 220019251 | 220006936 | 0 | 9.1 | Adjuvant (A) | 2017-03-25 | 2017-05-13 | null | N | N | 220026611 | NOT MATCHED |
| 220019252 | 220006938 | 0 | 9.7 | Curative (C) | null | 2018-01-01 | NB HRNBL-1 COJEC Ind COURSE C | 02 | N | 220026612 | NOT MATCHED |
| 220019253 | 220006941 | 1.68 | 12.1 | Curative (C) | 2015-04-11 | 2015-04-11 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN + METHOTREXATE | 2 | N | 220026614 | NOT MATCHED |
| 220019254 | 220006942 | 1.86 | null | Curative (C) | 2016-08-20 | 2016-08-20 | null | N | N | 220026621 | NOT MATCHED |
| 220019255 | 220006948 | 1.9 | 79.9 | null | 2014-12-26 | 2014-12-27 | Hydroxycarbamide | N | N | 220026636 | HYDROXYCARBAMIDE |
| 220019256 | 220006959 | 1.65 | 72.7 | Palliative (P) | 2016-09-22 | 2016-09-27 | Hydroxycarbamide | null | N | 220026681 | HYDROXYCARBAMIDE |
| 220019257 | 220006960 | 1.66 | 34 | Curative (C) | 2013-09-04 | 2013-09-04 | AML Relapsed High Dose Cytarabine | N | N | 220026683 | NOT MATCHED |
| 220019258 | 220013834 | 0 | null | Disease modification (D) | 2014-07-05 | 2014-09-27 | Cytarabine Low Dose | N | N | 220026693 | CYTARABINE |
| 220019259 | 220006965 | null | 54 | Disease modification (D) | 2015-01-08 | 2015-02-18 | AML Relapsed High Dose Cytarabine | 2 | N | 220026700 | NOT MATCHED |
| 220019260 | 220006967 | null | 69.5 | Palliative (P) | 2017-06-29 | 2017-10-04 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220026704 | CYTARABINE |
| 220019261 | 220020813 | 1.48 | null | null | null | 2018-05-27 | Hydroxycarbamide | N | N | 220026725 | HYDROXYCARBAMIDE |
| 220019262 | 220022261 | 1.6 | null | Curative (C) | null | 2016-02-21 | Hydroxycarbamide | 02 | N | 220026734 | HYDROXYCARBAMIDE |
| 220019263 | 220006976 | 1.81 | 0 | Adjuvant (A) | 2016-01-12 | 2016-03-19 | Hydroxycarbamide | null | N | 220026760 | HYDROXYCARBAMIDE |
| 220019264 | 220006981 | 1.56 | 107.5 | Disease modification (D) | 2017-06-15 | 2017-11-25 | Hydroxycarbamide | 2 | N | 220026769 | HYDROXYCARBAMIDE |
| 220019265 | 220006984 | 1.79 | null | Palliative (P) | 2014-08-18 | 2014-10-05 | CYTARABINE | N | N | 220026785 | CYTARABINE |
| 220019268 | 220006996 | null | 64 | null | 2016-08-06 | 2016-08-06 | Cytarabine Low Dose | N | N | 220026820 | CYTARABINE |
| 220019269 | 220006998 | 1.65 | 0 | Disease modification (D) | null | 2013-09-26 | Hydroxycarbamide | 02 | N | 220026826 | HYDROXYCARBAMIDE |
| 220019270 | 220007001 | null | 60 | Curative (C) | 2013-10-24 | 2014-01-04 | FBC Conditionining | 02 | N | 220026835 | NOT MATCHED |
| 220019271 | 220007003 | 1.63 | null | null | 2017-12-10 | 2017-12-10 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220026837 | CYTARABINE |